Institute of Pharmacology, Polish Academy of Sciences, Department of Medicinal Chemistry, 31-343, Kraków, Smętna Street 12, Poland.
Università degli Studi di Bari "Aldo Moro", Dipartimento di Farmacia - Scienze del Farmaco, 70125, Bari, Via Orabona 4, Italy.
Eur J Med Chem. 2018 May 10;151:797-814. doi: 10.1016/j.ejmech.2018.04.010. Epub 2018 Apr 6.
Identifying desired interactions with a target receptor is often the first step when designing new active compounds. However, attention should also be focused on contacts with other proteins that result in either selective or polypharmacological compounds. Here, the search for the structural determinants of selectivity between selected serotonin receptor subtypes was carried out. Special attention was focused on 5-HTR and the cross-interactions between its ligands and the 5-HTR, 5-HTR, 5-HTR, 5-HTR, and 5-HTR subtypes. Selective and non-selective compounds for each pair of 5-HT/5-HT receptors were docked to the respective 5-HTR homology models and 5-HT/5-HTR crystal structures. The contacts present in the ligand-receptor complexes obtained by docking were characterized by the structural interaction fingerprint and statistically analyzed in terms of their frequency. The results allowed for the identification of amino acids that discriminate between selective and non-selective compounds for each 5-HT/5-HT receptor pair, which was further compared with available mutagenesis data. Interaction pattern characteristics for compounds with particular activity profiles can constitute the basis for the coherent selectivity theory within a considered set of proteins, supporting the ongoing development of new ligands targeting these receptors. The in silico results were used to analyze prospective virtual screening results towards the 5-HT receptor in which compounds of different chemotypes to known 5-HTR ligands, with micromolar level activities were identified. The findings in this study not only confirm the legitimacy of the approach but also constitute a great starting point for further studies on 5-HTR ligands selectivity.
确定与目标受体的所需相互作用通常是设计新活性化合物的第一步。然而,还应关注与其他导致选择性或多药性化合物的蛋白质的接触。在这里,搜索了所选血清素受体亚型之间选择性的结构决定因素。特别关注 5-HTR 及其配体与 5-HTR、5-HTR、5-HTR、5-HTR 和 5-HTR 亚型之间的交叉相互作用。对每种 5-HT/5-HT 受体对的选择性和非选择性化合物进行对接,以获得各自的 5-HTR 同源模型和 5-HT/5-HTR 晶体结构。通过对接获得的配体-受体复合物中的接触通过结构相互作用指纹进行了表征,并根据其频率进行了统计分析。结果允许识别区分每种 5-HT/5-HT 受体对的选择性和非选择性化合物的氨基酸,进一步与可用的诱变数据进行比较。具有特定活性谱的化合物的相互作用模式特征可以构成考虑一组蛋白质内一致选择性理论的基础,支持针对这些受体的新配体的持续开发。在计算机上的结果用于分析针对 5-HT 受体的预期虚拟筛选结果,其中鉴定出了具有不同化学型的化合物,这些化合物对已知的 5-HTR 配体具有微摩尔水平的活性。本研究中的发现不仅证实了该方法的合法性,而且为进一步研究 5-HTR 配体的选择性提供了良好的起点。